Theme: Exploring new research and innovative development in Nephrology and Kidney Diseases
Euro Nephrology Summit 2023
Welcome message for the 11th European Congress on Nephrology, Internal Medicine, and Kidney Diseases.
Dear Colleagues and Medical Doctors:
On behalf of the organizing committee, it is an honor and a pleasure to announce the 11th European Congress on Nephrology, Internal Medicine, and kidney diseases that will be held on April 27-28th, 2023 in Paris, France.
It is our primary objective for the meeting to bring together up-and-coming researchers in the nephrology and internal medicine field to present up-to-date research results and clinical experiences in the diagnosis and treatment of Nephrology diseases such as diabetic Kidney disease, hypertension, Pediatric Kidney disease, Glomerular diseases, Kidney stone disease, Kidney transplant surgeons, and other researchers in Diet, kidney Disease.
Nothing will bring us more pleasure than seeing young professionals’ colleagues actively discussing their latest research and demonstrating their achievements.
Live academic meetings are historically known to be the best method for medical professionals to gather and disseminate information, share new knowledge, and set new evidence-based policies and guidelines.
At this conference, I will present my studies regarding energy alterations in patients with strokes and show how can we treat them, looking at the energy point of view.
I will be waiting for you at this prestigious conference and hope to see you at this online conference.
Dr. Huang Wei Ling
Medical Researcher Integrating Western and Traditional Chinese Medicine.
Euro Nephrology Summit 2023 welcomes every one of the members over the globe to go to the 11th European Congress on Nephrology, Internal Medicine and Kidney Diseases which will be held from April 27-28, 2023 at Paris, France concentrating on future strategies on Nephrology, Internal medication and Kidney Disease. The current year's yearly congress features the theme, ''Mastering Medicine towards Renal Care'' which will give a universal stage to dialogue and sharing original thoughts regarding present and future parts of Nephrology and Renal Care.
Scope and Importance:
The speed of progressions in nephrology has been stimulated by the assurance that new revelations may improve the thought of patients encountering renal ailment. This improvement is, all things considered, as a result of the expansion of the Chronic Kidney Diseases (CKD) getting masses, propelling human administrations transport models in a period of over the top budgetary necessity and mechanical progression modifying care movement to renal infection patients. To suit the heterogenic renal patient people and the wide arrangement of preparing settings, the nephrologist must be set up to fill in as the patient's fundamental thought provider or conceivably subspecialty master. The use of agreeable practice models in renal thought is fundamental to address the issues of this rapidly broadening patient mass.
The Target audience for conference are Nephrologists, Nephrology Scientists, Kidney Transplantation Surgeons, Nephrology Researchers, Urologists, Endocrinologists, Fellows or Postdoctoral students, Nephrology Academicians, Nephrology Associations and Societies, Business Entrepreneurs, Manufacturing Medical Devices Companies, Young research scientists, Medical Colleges, Emeritus and Training Institutes.
Kaneka Pharma Company
NxStage Medical, Inc.
Storz Medical AG
EDAP TMS S.A
Dornier MedTech GmbH
Nikkiso CO., LTD.
Medline Industries, Inc.
Asahi Kasei Corporation
Baxter International Inc.
DaVita HealthCare Partners Inc.
Keryx Biopharmaceuticals, Inc.
Nephrology and Urology Devices Market Analysis Report By Type (Dialysis, Benign Prostatic Hyperplasia, Endoscopy, Urinary Stone, Urinary Incontinence & Pelvic Organ Prolapse), And Segment Forecasts, 2018 - 2024
The world nephrology and urology devices market dimension was once estimated at USD 18.03 billion in 2016 and is expected to increase at a CAGR of 7.1% over the forecast period. Increasing prevalence of kidney failure and end-stage renal ailments has resulted in scientific urgency for units that can enhance current patient effects and curb long-term fees related with treatment of kidney diseases. According to a lookup published in Medscape, kidney failure is one of the foremost causes for excessive mortality charge in U.S. As mentioned in a lookup published in NCBI, end-stage renal sickness is a major value driver in most healthcare structures throughout developed economies. The market is pushed with the aid of technological developments in these devices such as extracorporeal shockwave lithotripsy, percutaneous strategies for stone disintegration and extraction, and inclusion of prosthetics in urology. These technologies also minimize the likelihood of recurrence of stone formation and are being increasingly integrated in pediatric urology.
- Hypertension associated with Kidney Diseases
- Diabetic Nephropathy
- Pediatric Nephrology
- Clinical Nephrology
- Drugs used in the treatment of Kidney Diseases
- Stages of Kidney Diseases
- Kidney Transplantation
- Glomerular Disease
- Kidney Stones
- Nephrotic Syndrome
- Cardiorenal Syndrome
- Hereditary Kidney Disorders
- Diet for Kidney Health
- Biomarkers of Kidney Diseases
- Technological Advancements in Nephrology
- Stem cells in Renal Disorders
- Diagnostic, Imaging and Radiation Techniques
To share your views and research, please click here to register for the Conference.
All accepted abstracts will be published in respective Our International Journals.
- Journal of Nephrology & Therapeutics
- Journal of Transplantation Technologies & Research
- Journal of Clinical and Experimental Nephrology
Abstracts will be provided with Digital Object Identifier by